AGGF1 Rekombinanter Antikörper
AGGF1 Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
242264E9
Kat-Nr. : 84715-3-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
84715-3-PBS bindet in WB, Indirect ELISA AGGF1 und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | AGGF1 fusion protein Ag2497 |
Vollständiger Name | angiogenic factor with G patch and FHA domains 1 |
Berechnetes Molekulargewicht | 714 aa, 81 kDa |
Beobachtetes Molekulargewicht | 84-100 kDa |
GenBank-Zugangsnummer | BC029382 |
Gene symbol | AGGF1 |
Gene ID (NCBI) | 55109 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein A purfication |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
The angiogenic factor gene, AGGF1 (or VG5Q), is identified as a candidate susceptibility gene for Klippel-Trenaunay syndrome (KTS) which is a severe congenital disorder characterized by capillary malformations, venous malformations or varicose veins, and hypertrophy of the affected tissues. AGGF1 protein can bind to endothelial cells and promote cell proliferation. AGGF1 shows strong expression in blood vessels and is secreted as vessel formation is initiated. Regulation of AGGF1 by GATA1 may play roles in endothelial cell biology and angiogenesis.